e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Improving asthma control in the harder-to-reach population
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
F. Blasi, R. B. Nieman, P. N. Black, S. L. Johnston (Milan, Italy; Bridgewater, United States Of America; Auckland, New Zealand; London, United Kingdom)
Source:
Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Session:
Improving asthma control in the harder-to-reach population
Session type:
Oral Presentation
Number:
3052
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Blasi, R. B. Nieman, P. N. Black, S. L. Johnston (Milan, Italy; Bridgewater, United States Of America; Auckland, New Zealand; London, United Kingdom). Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study. Eur Respir J 2005; 26: Suppl. 49, 3052
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Mechanisms of exacerbation of respiratory symptoms in patients with COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
COPD exacerbations in old age: how to prevent, detect and treat
Source: Eur Respir Mon; 2009: 43: 90–110
Year: 2009
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003
Severe exacerbations predict excess lung function decline in asthma
Source: Eur Respir J 2007; 30: 452-456
Year: 2007
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Roflumilast with long-acting ?2-agonists for COPD: influence of exacerbation history
Source: Eur Respir J 2011; 38: 553-560
Year: 2011
Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006
Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006
Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Prolonging the interval to the next acute exacerbations
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Resistance to resistance
Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies"
Year: 2007
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT(R) trial
Source: Eur Respir J 2010; 36: 65-73
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept